GS0421: Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials for others; basic and clinical research in the field of health care and medicine; Clinical and medical research, data collection and scientific analysis to the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease; creating and hosting an online community website relating to patients with rare diseases; pharmaceutical research services, namely, recruitment of rare disease patients for panels in the nature of pharmaceutical research panels; design and development of computer software; platform as a service (PAAS) featuring computer software platforms for clinical trial patient lead management and enrollment; Platform as a service (PAAS) featuring computer software platforms for clinical trials; Platform as a service (PAAS) featuring computer software platforms for patient and physician market research; Platform as a service (PAAS) featuring computer software platforms for education about rare diseases and treatment received
Case File Event Statements
12/5/2023 - a year ago
5 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
3/3/2023 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
3/20/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
11/28/2023 - a year ago
3 - ASSIGNED TO EXAMINERType:DOCK
12/5/2023 - a year ago
4 - EXAMINERS AMENDMENT -WRITTENType:CNEA
12/5/2023 - a year ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
12/5/2023 - a year ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
12/5/2023 - a year ago
8 - EXAMINERS AMENDMENT -WRITTENType:CNEA
12/5/2023 - a year ago
9 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
12/5/2023 - a year ago
10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
12/5/2023 - a year ago
11 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
12/6/2023 - a year ago
12 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/9/2024 - 11 months ago
15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/20/2023 - a year ago
13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
1/9/2024 - 11 months ago
14 - PUBLISHED FOR OPPOSITIONType:PUBO
3/5/2024 - 10 months ago
16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
4/3/2024 - 9 months ago
17 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
8/9/2024 - 4 months ago
18 - SOU TEAS EXTENSION RECEIVEDType:EEXT
8/9/2024 - 4 months ago
21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA